Buscar
Baxter International Inc
BAXAñadir a la lista de seguimiento
26.160USD
-0.600-2.24%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
13.45BCap. mercado
PérdidaP/E TTM
Más Datos de Baxter International Inc Compañía
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Información de Baxter International Inc
Símbolo de cotizaciónBAX
Nombre de la empresaBaxter International Inc
Fecha de salida a bolsaJun 20, 2097
Director ejecutivoHider (Andrew P)
Número de empleados38000
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 20
DirecciónOne Baxter Parkway
CiudadDEERFIELD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal60015
Teléfono12249482000
Sitio Webhttps://www.baxter.com/
Símbolo de cotizaciónBAX
Fecha de salida a bolsaJun 20, 2097
Director ejecutivoHider (Andrew P)
Ejecutivos de Baxter International Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
28.89K
+44.43%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
23.66K
+54.26%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
20.92K
+61.36%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+43.66%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Baxter International Inc?
Los cinco principales accionistas de Baxter International Inc son: Mr. Andrew P. Hider
¿Cuántas instituciones poseen acciones de Baxter International Inc (BAX)?
A fecha de 2026Q1, 1767 instituciones poseen acciones de Baxter International Inc, con un valor de mercado combinado de aproximadamente 557.84M, lo que representa el 108.01% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -45350754.00.
¿Cuál es la mayor fuente de ganancias de Baxter International Inc?
El 2026Q1, el segmento empresarial Infusion Therapies and Technologies generó la ganancia más alta para Baxter International Inc, ascendiendo a 4.10B y representando el 36.47% de la ganancia total.